NCT01234597 - Evaluation of the Prandial Treatment Adjustment Effect Via Continuous Glucose Monitoring on Type 2 Diabetes Mellitus (DM) Patients Uncontrolled With a Basal Insulin or Premix Once a Day | Biotech Hunter

Enrollment

219

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

INSULIN GLARGINE (HOE901)

Pharmaceutical form: solution for injection Route of administration: subcutaneous

DRUG

INSULIN GLULISINE (HMR1964)

Pharmaceutical form:Solution for injection Route of administration: Subcutaneous

Trial Locations (11)

Investigational Site Number 376004, Kfar Saba

Investigational Site Number 376003, Beersheba

Investigational Site Number 376007, Haifa

Investigational Site Number 376012, Lod

Investigational Site Number 376013, Nazareth

Investigational Site Number 376006, Netanya

Investigational Site Number 376001, Ramat Gan

Investigational Site Number 376009, Sakhnin

Investigational Site Number 376008, Tel Aviv

Investigational Site Number 376010, Tel Aviv

Investigational Site Number 376011, Tel Aviv